Siming Li
Impact in
- Oncology top 5%
- Cutaneous Melanoma Detection and Management
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Biochemistry top 5%
Papers in
- Oncology 50
- Cancer Immunotherapy and Biomarkers 26
- Cutaneous Melanoma Detection and Management 23
- CAR-T cell therapy research 17
-
- Melanoma and MAPK Pathways 13
- Co-authors
- Xinan Sheng (59 shared papers)Lu Si (57 shared papers)Chuanliang Cui (56 shared papers)Zhihong Chi (50 shared papers)Bixia Tang (55 shared papers)Bin Lian (50 shared papers)Jun Guo (38 shared papers)Yan Kong (30 shared papers)
- Journals
- Journal of Clinical Oncology (26 papers)European Journal of Cancer (6 papers)Evidence-based Complementary and Alternative Medicine (3 papers)Scientific Reports (2 papers)Urologic Oncology Seminars and Original Investigations (2 papers)
- Partner nations
- ChinaUnited StatesEthiopia
In The Last Decade
Siming Li
82 papers receiving 1.8k citations
Siming Li's Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 732
- Biochemistry 105
- Cancer Research 215
- Immunology 291
- Complementary and alternative medicine 90
Countries citing papers authored by Siming Li
This map shows the geographic impact of Siming Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siming Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siming Li more than expected).
Fields of papers citing papers by Siming Li
This network shows the impact of papers produced by Siming Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siming Li. The network helps show where Siming Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Siming Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP Hit paper breakdown → | 2005 | 513 |
| 2 | 2013 | 121 | |
| 3 | 2021 | 88 | |
| 4 | 2019 | 51 | |
| 5 | 2016 | 49 | |
| 6 | 2015 | 47 | |
| 7 | 2014 | 39 | |
| 8 | 2018 | 37 | |
| 9 | 2021 | 36 | |
| 10 | 2017 | 35 | |
| 11 | 2018 | 35 | |
| 12 | 2022 | 35 | |
| 13 | 2018 | 34 | |
| 14 | 2013 | 34 | |
| 15 | 2022 | 33 | |
| 16 | 2020 | 32 | |
| 17 | 2020 | 30 | |
| 18 | 2017 | 29 | |
| 19 | 2022 | 29 | |
| 20 | 2011 | 27 |
About Siming Li
Siming Li is a scholar working on Oncology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Immunology, having authored 85 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (26 papers), Cutaneous Melanoma Detection and Management (23 papers), CAR-T cell therapy research (17 papers), Bladder and Urothelial Cancer Treatments (16 papers), Melanoma and MAPK Pathways (13 papers), Immunotherapy and Immune Responses (11 papers), Renal cell carcinoma treatment (10 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Oncology (732 citations), Biochemistry (105 citations), Cancer Research (215 citations), Immunology (291 citations) and Complementary and alternative medicine (90 citations). Siming Li has collaborated with scholars based in China, United States and Ethiopia. Frequent co-authors include Xinan Sheng, Lu Si, Chuanliang Cui, Zhihong Chi, Bixia Tang, Bin Lian, Jun Guo, Yan Kong, Jiandie D. Lin and Lili Mao. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Evidence-based Complementary and Alternative Medicine, Scientific Reports and Urologic Oncology Seminars and Original Investigations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.